doi: 10.1016/J.FOODCHEM.2023.138164 101 HanJ.LinC.ZhuT.LiuY.YanJ.QiZ.et al
High dose intravenous (IV) thiamine supplementation (500 mg thiamin dissolved in 100 mL normal saline) led to a reduction in the frequency of migraine attacks ( Mitochondrial dysfunction theory is one of the hypotheses related to thiamine-migraine association ( Riboflavin Riboflavin is one of the most essential vitamins B due to its properties, such as anti-inflammatory, antioxidant, anti-nociceptive, and anti-aging ( Disruption in brain energy metabolism is considered a proposed cause of migraine attacks ( A randomized clinical trial (RCT) demonstrated that high-dose riboflavin supplementation (400 mg/d) could decrease the attack frequency, duration, severity, and number of headache days in adults with migraine, after 3 months
(The third, Foundayo, just got FDA approval in April, so its too new for spending data.) In 2024, Medicare spent over $19.3 billion on Ozempic and Mounjaro, according to gross spending data from CMS
LyssenkoVEliassonLKotovaOPilgaardKWierupNSalehiAet al
Olympia Pharmaceuticals 503B Compounding Olympia Pharmaceuticals is the nations leading and most advanced 503B outsourcing facility, trusted by hundreds of thousands of providers, pharmacies, and patients across the country